Recombinant Human Interleukin-11 (rhIL-11) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

The First Affiliated Hospital with Nanjing Medical University1

Indications

CTIT: Cancer Therapy Induced Thrombocytopenia1
Cancer1

Other1 trial

A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.